![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 20-Mar-2013[ | E-mail |
Share ] Contact: Helen Habernickel
h.habernickel@elsevier.com
49-306-449-20374
Elsevier
Munich, March 20, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Wound Medicine The International Wound Journal for Clinical and Health Economics Research and Applications.
Published in print and online four times a year Wound Medicine is devoted to the clinical, scientific and health economics aspects in the prevention, management and reimbursement in wound care. The journal publishes original research papers and review articles. In addition, the journal will feature standards and guidelines, commentaries, health economic analyses and selected conference papers that meet the information need of wound care specialists and service providers.
Thomas Wild and Thomas Eberlein, both from the Wound Academy in Hamburg and University Medical Center Hamburg-Eppendorf, founded the journal. Together with a prestigious international editorial team they aim to cover themes central to the journal such as: tissue repair and wound healing, diabetic foot syndrome, clinical trials and outcomes, health care and economics and service delivery. Their vision for Wound Medicine is to advance the translation of science into clinical practice and application, to improve outcomes and the patient experience.
"We are convinced that Wound Medicine will facilitate the development of standards and enhance guidelines benefitting health care professionals in and beyond Europe by putting emphasis on health improvement and economic benefits," said Thomas Wild, "The journal has been launched to provide a home for translational wound research, and we welcome submissions from all affiliated clinical fields."
"We are excited about the launch of Wound Medicine which will cover the rapidly developing area of wound care, a subject of ever increasing importance," added Helen Habernickel, Publishing Editor at Elsevier. "Our aging and diabetes prone population is at an increased risk of developing chronic wounds while normal wound healing decreases with age. This journal will provide a publication platform for the advances made in wound research."
###
For more information or to submit an article, go to: http://www.elsevier.com/journals/wound-medicine/2213-9095
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 20-Mar-2013[ | E-mail |
Share ] Contact: Helen Habernickel
h.habernickel@elsevier.com
49-306-449-20374
Elsevier
Munich, March 20, 2013 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Wound Medicine The International Wound Journal for Clinical and Health Economics Research and Applications.
Published in print and online four times a year Wound Medicine is devoted to the clinical, scientific and health economics aspects in the prevention, management and reimbursement in wound care. The journal publishes original research papers and review articles. In addition, the journal will feature standards and guidelines, commentaries, health economic analyses and selected conference papers that meet the information need of wound care specialists and service providers.
Thomas Wild and Thomas Eberlein, both from the Wound Academy in Hamburg and University Medical Center Hamburg-Eppendorf, founded the journal. Together with a prestigious international editorial team they aim to cover themes central to the journal such as: tissue repair and wound healing, diabetic foot syndrome, clinical trials and outcomes, health care and economics and service delivery. Their vision for Wound Medicine is to advance the translation of science into clinical practice and application, to improve outcomes and the patient experience.
"We are convinced that Wound Medicine will facilitate the development of standards and enhance guidelines benefitting health care professionals in and beyond Europe by putting emphasis on health improvement and economic benefits," said Thomas Wild, "The journal has been launched to provide a home for translational wound research, and we welcome submissions from all affiliated clinical fields."
"We are excited about the launch of Wound Medicine which will cover the rapidly developing area of wound care, a subject of ever increasing importance," added Helen Habernickel, Publishing Editor at Elsevier. "Our aging and diabetes prone population is at an increased risk of developing chronic wounds while normal wound healing decreases with age. This journal will provide a publication platform for the advances made in wound research."
###
For more information or to submit an article, go to: http://www.elsevier.com/journals/wound-medicine/2213-9095
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-03/e-eat032013.php
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.